Anibal Avila, MD in Oklahoma City: Addiction Medicine Treatment and Recovery Support

Anibal Avila, MD is a board-certified addiction medicine physician in Oklahoma City who evaluates and treats patients with substance use disorders, alcohol dependence, and opioid use disorder, with a focus on medication-assisted treatment (MAT) and discharge planning to support long-term recovery. The practice operates within Oklahoma's regulated medical system and serves both insured and self-pay patients seeking structured addiction care rather than detoxification-only or peer-support alternatives.

What Anibal Avila, MD Actually Offers

Addiction medicine is a distinct medical specialty that diagnoses and manages substance use disorders using pharmacotherapy, behavioral assessment, and referral coordination. Avila's practice typically handles initial evaluation for use disorder severity, medical history relevant to addiction (liver function, cardiac status, psychiatric comorbidity), and determination of appropriate treatment modality. Addiction medicine physicians do not operate detoxification units; they prescribe and monitor medications like buprenorphine, naltrexone, and methadone when appropriate, and refer to inpatient or intensive outpatient programs when detoxification is needed before or during medication initiation. The specialty bridges primary care and psychiatry, requiring medical knowledge of withdrawal protocols, drug interactions, and substance-specific complications.

Services and Treatment Modalities

Avila's practice generally includes:

Evaluation and diagnosis of opioid use disorder, alcohol use disorder, stimulant use disorder, and polysubstance dependence according to DSM-5 criteria. Initial visits typically run 60 to 90 minutes and include medical history, substance history (timeline, quantity, route), social and psychiatric screening, and laboratory work (urine drug screen, liver function tests, HIV status if indicated).

Buprenorphine management, which is office-based partial opioid agonist therapy. Buprenorphine requires a DEA waiver to prescribe; physicians with this waiver (often called "X-waivered") can treat up to 100 or 275 patients depending on application. Routine visits are typically 15 to 30 minutes and spaced every 2 to 4 weeks once stable.

Naltrexone prescription, a full opioid antagonist used for opioid and alcohol use disorder, typically as a monthly injectable (Vivitrol) or daily tablet. Naltrexone requires 7 to 10 days of abstinence before initiation, making it less suitable than buprenorphine for immediate inpatient transition.

Referral to medically supervised detoxification, intensive outpatient programs (IOP), and inpatient residential treatment when needed. Avila's role includes determining level of care and coordinating with these programs.

Medication management during treatment, including monitoring for diversion risk, adjusting doses, managing drug interactions, and addressing psychiatric symptoms that often co-occur with addiction.

Pricing is typically fee-for-service, with initial evaluations ranging from $150 to $300 depending on complexity and insurance coverage. Follow-up visits run $75 to $150. Many insurance plans, including Medicaid in Oklahoma and commercial policies, cover addiction medicine evaluation and MAT; self-pay patients should confirm costs directly. Some community health centers in Oklahoma City offer sliding-scale addiction medicine services, which may be lower but often involve waitlists.

How Avila Compares to Other Oklahoma City Addiction Medicine Options

Oklahoma City residents have limited board-certified addiction medicine specialists. Many patients are instead referred to:

Community health centers such as those operated by the Oklahoma City Health Department or federally qualified health centers (FQHCs), which offer buprenorphine prescribing and counseling on a sliding-fee scale but may have longer wait times (2 to 6 weeks) and group visits rather than individual physician appointments.

Methadone maintenance programs, which are opioid treatment programs (OTPs) regulated by SAMHSA and state boards. These require daily clinic visits initially, making them suitable for unstable patients but inconvenient for employed individuals. A board-certified addiction medicine physician like Avila can manage buprenorphine in an office, allowing more flexibility.

Primary care physicians with X-waivers, often family medicine or internal medicine doctors who also manage addiction. They may have shorter wait times but less specialized training in complex cases (multiple substance use, significant psychiatric illness, medical complications).

Psychiatric or dual-diagnosis programs, which treat co-occurring mental illness and addiction; these differ from pure addiction medicine practices because they prioritize mood or anxiety disorder management alongside substance use treatment.

Choose Avila's practice if you have completed detoxification or do not need it, prefer a specialist-level evaluation, have insurance that covers his services, and want flexible office-based buprenorphine or naltrexone management. Choose an FQHC if you are uninsured or underinsured and can tolerate a waitlist. Choose an OTP program if you require methadone or have failed office-based buprenorphine. Choose a dual-diagnosis program if psychiatric hospitalization or inpatient psychiatric care is your priority.

Who It Suits and Who It Does Not

Avila's practice is suited for patients with opioid use disorder, alcohol use disorder, or stimulant use disorder who:

Are medically stable or have controlled chronic illness (no active seizures, hepatic encephalopathy, or acute withdrawal at the time of evaluation).

Are motivated to engage in office-based care and can attend appointments every 2 to 4 weeks.

Do not require daily supervision (this rules out many early-recovery patients or those at high diversion risk).

Have insurance or funds to pay out-of-pocket for specialist visits.

Are not currently in acute withdrawal or overdose crisis.

It does not suit patients in acute withdrawal without prior detoxification, those without transportation to a regular appointment schedule, those requiring involuntary psychiatric hold or 24-hour monitoring, or those with untreated psychosis or acute suicidality requiring psychiatric hospitalization first.

What the First Visit Involves

You will complete a detailed substance use history (age of first use, current daily use or amount, previous withdrawal symptoms, prior treatment attempts, and any medical consequences). Avila will review psychiatric history, medical history, family history of addiction, employment and housing status, and social support. A physical exam assesses for signs of injection use (track marks, abscesses), withdrawal (tremor, elevated heart rate, diaphoresis), or organ damage. Laboratory tests include urine drug screen (comprehensive panel covering opioids, benzodiazepines, stimulants, THC), liver function tests (AST, ALT, GGT), hepatitis C and HIV screening if risk factors present, and sometimes EKG for stimulant users. At the end of the visit, a treatment plan is outlined, usually specifying buprenorphine initiation with a target dose, a schedule for follow-up visits, and referrals to behavioral health counseling or IOP if indicated. Most patients leave with a buprenorphine prescription to begin at home within one to three days, allowing time to experience mild early withdrawal to avoid precipitated withdrawal.

Hours, Parking, and Logistics

Office-based addiction medicine practices typically operate during standard business hours, Monday through Friday, 8 a.m. to 5 p.m., with some offering extended or Saturday hours. Confirm Avila's specific hours directly, as scheduling can vary. Parking in Oklahoma City medical office complexes is usually free and ample. If Avila's practice is co-located with a hospital system or larger medical center, parking directions should be available on the practice website or phone line. Plan for an initial visit lasting 90 minutes; follow-ups are 20 to 30 minutes. If you are in withdrawal at the time of appointment, contact the office in advance to discuss whether to proceed or seek urgent care or detoxification first.

Anibal Avila, MD fills a gap in Oklahoma City's addiction medicine landscape by offering specialist-level evaluation and office-based medication management for patients with access to insurance and stability to maintain regular appointments.